Matches in Nanopublications for { ?s ?p "[Thus, SUM-102PT is a new human breast cancer cell line that expresses activated EGFR as a result of an autocrine/juxtacrine interaction with HB-EGF which, in turn, results in activation of STAT-3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- assertion description "[Thus, SUM-102PT is a new human breast cancer cell line that expresses activated EGFR as a result of an autocrine/juxtacrine interaction with HB-EGF which, in turn, results in activation of STAT-3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Thus, SUM-102PT is a new human breast cancer cell line that expresses activated EGFR as a result of an autocrine/juxtacrine interaction with HB-EGF which, in turn, results in activation of STAT-3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1367830.RAat3eLRfPy0q5nqG_776wd6BFj3rvT_kHRkl0Nh0nJiY130_assertion description "[Thus, SUM-102PT is a new human breast cancer cell line that expresses activated EGFR as a result of an autocrine/juxtacrine interaction with HB-EGF which, in turn, results in activation of STAT-3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1367830.RAat3eLRfPy0q5nqG_776wd6BFj3rvT_kHRkl0Nh0nJiY130_provenance.
- NP1367828.RAG3BroBB0HZ0yHUS-1XAti6ErMtMWFQWbG0HBvFhKDsc130_assertion description "[Thus, SUM-102PT is a new human breast cancer cell line that expresses activated EGFR as a result of an autocrine/juxtacrine interaction with HB-EGF which, in turn, results in activation of STAT-3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1367828.RAG3BroBB0HZ0yHUS-1XAti6ErMtMWFQWbG0HBvFhKDsc130_provenance.
- NP1367831.RAEnMFhh_MhZRefNPMjli0S6LaqK9EyN1N51Qi63riAJM130_assertion description "[Thus, SUM-102PT is a new human breast cancer cell line that expresses activated EGFR as a result of an autocrine/juxtacrine interaction with HB-EGF which, in turn, results in activation of STAT-3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1367831.RAEnMFhh_MhZRefNPMjli0S6LaqK9EyN1N51Qi63riAJM130_provenance.
- NP1367832.RAvVVOpzZwwSxv3nZxHrQr6C_WYuw8BESE_tXsrwy9X68130_assertion description "[Thus, SUM-102PT is a new human breast cancer cell line that expresses activated EGFR as a result of an autocrine/juxtacrine interaction with HB-EGF which, in turn, results in activation of STAT-3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1367832.RAvVVOpzZwwSxv3nZxHrQr6C_WYuw8BESE_tXsrwy9X68130_provenance.